: ' OxyContin'

PROP’s Petition: Why Opioid Labeling Changes Are Needed

By Pete Jackson, Guest Columnist Recently, several columns have appeared in American News Report expressing negative views toward a petition submitted to the FDA by doctors, researchers and public health officials, many of them associated with [...]

FDA’s Painkiller Education Campaign Criticized

Two pain management physicians are criticizing plans by the Food and Drug Administration for a voluntary educational campaign for doctors on the risks and benefits of prescribing opioid painkillers. The FDA’s risk evaluation and mitigation strategy [...]

Bill Would Force Drug Makers to Make Painkillers Tamper Resistant

A bipartisan effort in Congress to make more opioid painkillers tamper resistant could also make generic forms of the drugs more costly, according to experts. Rep. Mary Bono Mack (R-California) and Rep. Bill Keating (D-Massachusetts) have [...]

Are Painkiller Sales Falling?

Sales of OxyContin and other popular painkillers in the U.S. have declined in the past year, according to pharmaceutical sales data released by a clinical drug website. But it’s not clear if the drop in sales [...]

New OxyContin Formula Has Many Abusers Switching to Heroin

A change in the formula for the powerful painkiller OxyContin – designed to make the drug less likely to be abused — may be encouraging the use of more dangerous drugs. Many abusers are switching from [...]

Should Children Take Opioid Painkillers?

Two new studies are drawing attention to a sensitive topic in the pain community: Should children be given powerful and potentially addictive opioid analgesics to relieve their pain? According to research published in Pain Management Nursing, [...]

The Government’s War on Pain Doctors Revisited

Editor’s Note: Linda Cheek  is a family practice and alternative medicine physician in southwest Virginia. In February, Cheek wrote a column for American News Report discussing her efforts to treat pain patients, which were labeled a [...]

Abbott Laboratories Learns a Costly Lesson About Off-Label Marketing

Abbott Laboratories pleaded guilty earlier this month in federal court to marketing an anti-seizure drug called Depakote for unapproved purposes. The company will pay $1.5 billion in civil and criminal penalties to settle the case with [...]

Intermezzo: A Nightmare Drug for Insomniacs?

A new sleeping pill is on the market for patients with insomnia. Its name is Intermezzo and what makes this sleeping pill unique and potentially dangerous is that it is for “middle of the night” insomnia. The [...]

West Virginia Uses OxyContin Settlement Money to Build Gym

In 2001, Darrell McGraw Jr.,West Virginia’s attorney general, filed a civil case against Purdue Pharma, maker of a controversial and highly addictive drug, alleging that the pharmaceutical company had engaged in “coercive and deceptive” marketing of [...]